Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy
dc.contributor.author | Vickaryous, N | en_US |
dc.contributor.author | Asardag, AN | en_US |
dc.contributor.author | Chance, R | en_US |
dc.contributor.author | Jones, M | en_US |
dc.contributor.author | Bestwick, J | en_US |
dc.contributor.author | Shah, SN | en_US |
dc.contributor.author | George, K | en_US |
dc.contributor.author | Schmierer, K | en_US |
dc.contributor.author | Giovannoni, G | en_US |
dc.contributor.author | Baker, D | en_US |
dc.contributor.author | Kang, A | en_US |
dc.contributor.author | Dobson, R | en_US |
dc.date.accessioned | 2021-12-07T11:54:35Z | |
dc.date.issued | 2021 | en_US |
dc.identifier.issn | 1352-4585 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/75630 | |
dc.description | Meeting Abstract | en_US |
dc.format.extent | 775 - 776 | en_US |
dc.relation.ispartof | MULTIPLE SCLEROSIS JOURNAL | en_US |
dc.title | Seroconversion following vaccination against SARS-CoV-2 in people with MS: impact of disease modifying therapy | en_US |
dc.type | Article | |
pubs.author-url | https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000706771302332&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 2_SUPPL | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 27 | en_US |
rioxxterms.funder | Default funder | en_US |
rioxxterms.identifier.project | Default project | en_US |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |